1. Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and the EHRA Practical Guide. (1st April 2021) Authors: Capiau, Andreas; De Backer, Tine; Grymonprez, Maxim; Lahousse, Lies; Van Tongelen, Inge; Mehuys, Els; Boussery, Koen Journal: International journal of cardiology Issue: Volume 328(2021) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chronic obstructive pulmonary disease and the development of atrial fibrillation. (1st February 2019) Authors: Grymonprez, Maxim; Vakaet, Vincent; Kavousi, Maryam; Stricker, Bruno H.; Ikram, M. Arfan; Heeringa, Jan; Franco, Oscar H.; Brusselle, Guy G.; Lahousse, Lies Journal: International journal of cardiology Issue: Volume 276(2019) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis. Issue 2 (23rd December 2020) Authors: Grymonprez, Maxim; Steurbaut, Stephane; De Sutter, An; Lahousse, Lies Journal: Open heart Issue: Volume 7:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of P‐glycoprotein and/or CYP3A4‐interacting drugs on effectiveness and safety of non‐vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: A meta‐analysis. Issue 7 (21st February 2022) Authors: Grymonprez, Maxim; Vanspranghe, Kevin; Capiau, Andreas; Boussery, Koen; Steurbaut, Stephane; Lahousse, Lies Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 7(2022) Page Start: 3039 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta‐analysis on the obesity paradox. Issue 5 (26th March 2021) Authors: Grymonprez, Maxim; Capiau, Andreas; De Backer, Tine L.; Steurbaut, Stephane; Boussery, Koen; Lahousse, Lies Journal: Clinical cardiology Issue: Volume 44:Issue 5(2021) Page Start: 599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort study. Issue 4 (17th November 2022) Authors: Grymonprez, Maxim; De Backer, Tine L.; Capiau, Andreas; Vauterin, Delphine; Mehuys, Els; Boussery, Koen; Steurbaut, Stephane; Lahousse, Lies Journal: British journal of clinical pharmacology Issue: Volume 89:Issue 4(2023) Page Start: 1360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis. Issue 6 (22nd December 2021) Authors: Grymonprez, Maxim; Simoens, Cynthia; Steurbaut, Stephane; De Backer, Tine L; Lahousse, Lies Journal: Europace Issue: Volume 24:Issue 6(2022) Page Start: 887 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗